Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren’s syndrome.
March 29th, 2008 | by admin |Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren\’s syndrome.
Sánchez-Cano D, Callejas-Rubio J, Lara-Jiménez M, López-Trascasa M, Circadi M, Ortego-Centeno N.
Hospital Universitario San Cecilio, Unidad de Enfermedades Autoinmunes Sistémicas, Granada, Spain.